The 6 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 23.50, with a high estimate of 50.00 and a low estimate of 14.00. The median estimate represents a +210.03% increase from the last price of 7.58.
The current consensus among 7 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.91
Reporting Date Mar 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.